Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation
Open Access
- 2 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (6), 785-791
- https://doi.org/10.1093/europace/euq049
Abstract
Amiodarone is associated with significant adverse effects. We hypothesized that episodic amiodarone treatment would be associated with better quality of life (QoL) compared with continuous treatment in the prevention of recurrent atrial fibrillation (AF). Quality of life was assessed in 158 patients from the Continuous vs. Episodic Prophylactic Treatment with Amiodarone for the Prevention of AF (CONVERT) study, using the Short Form (SF)-36 health survey and University of Toronto AF Severity Scale (AF severity scale) questionnaires at baseline and 1 year. The episodic group received amiodarone 1 month peri-cardioversion, the continuous group continued amiodarone. Patients were assessed for major adverse events and maintenance of sinus rhythm during follow-up (i.e. no AF recurrences at every follow-up visit). Quality of life (assessed by SF-36 and AF severity scale) was comparable between both treatment groups at baseline and 12 months, with similar incidence rates of major adverse events. Fewer patients in the episodic group had maintenance of sinus rhythm during follow-up [27 (36%) vs. 49 (59%), P = 0.004]. In the episodic group, maintenance of sinus rhythm was associated with a significant improvement on four SF-36 subscales and AF severity scale at 12 months. In contrast, in the continuous group no significant differences in QoL were seen between patients with continued maintenance of sinus rhythm compared with those with AF recurrence at the end of follow-up. Quality of life was comparable in the episodic and continuous treated group after 12 months of follow-up. Continued maintenance of sinus rhythm was associated with an improvement in QoL in the episodic but not the continuous treated group.This publication has 15 references indexed in Scilit:
- Quality of Life with Defibrillator Therapy or Amiodarone in Heart FailureThe New England Journal of Medicine, 2008
- Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of InterventionsJournal of Cardiovascular Electrophysiology, 2008
- Management of atrial fibrillation in patients with heart failureEuropean Heart Journal, 2007
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterThe New England Journal of Medicine, 2007
- Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program SubstudyJournal of the American College of Cardiology, 2006
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summaryEuropean Heart Journal, 2006
- Amiodarone versus Sotalol for Atrial FibrillationThe New England Journal of Medicine, 2005
- Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: Results from the Rate Control Versus Electrical Cardioversion (RACE) studyJournal of the American College of Cardiology, 2004
- Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous systemEuropean Heart Journal, 2001
- Amiodarone to Prevent Recurrence of Atrial FibrillationThe New England Journal of Medicine, 2000